Processing Magazine

Bristol-Myers, Simcere Sign Development Deal

November 4, 2010
The Associated Press reports, Bristol-Myers Squibb Co. and Simcere Pharmaceutical Group said they will develop a potential cancer treatment. Under the deal, the companies will develop BMS-817378, which is still in the laboratory stage of development. Simcere, based in China, receives exclusive rights to develop and sell the product in China while New York-based Bristol-Myers Squibb retains exclusive rights in all other markets. Financial details of the deal were not disclosed.

Click here for more Industry News...